port-wine stain
Conditions
Interventions
Group A:receiving 20 minutes' irradiation
Control group:receiving 20 minutes' irradiation
Sponsors
Peking University First Hospital
Eligibility
Sex/Gender
All
Age
16 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients were eligible for study enrolment if they were aged between 16 and 65 years with clinically diagnosed port-wine stain. The therapy area should receive no isotope treatment previously, neither systemic treatment for port-wine stain during the past 4 weeks, nor topical treatment during the past 2 weeks. All patients were given written informed consent before any study-related tests were done. If the patient is younger than 18 years, the guardian's written informed consent was also obtained. Patients were required to have adequate haematological, renal, and hepatic function.
Exclusion criteria
Exclusion criteria: The main exclusion criteria were: Other vascular malformation, vessel related syndromes or other skin diseases that may interfere with the study evaluation; known to be allergic to porphyrins or its analogues; patients with photosensitivity or porphyria; allergic constitution or scar diathesis; immunocompromised patients; patients with electrocardiographic abnormality or known organic heart disease, coagulation disorders, psychiatric disease or severe endocrinopathy; taken known photosensitizer during the past 3 month; pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| effecacy; | — |
Countries
China
Contacts
Public ContactZhu Xue-jun
Outcome results
None listed